circRNA basic information
circBase ID: hsa_circ_0007380
Name: hsa_circ_NSUN2
Synonym: circNSUN2 / circ_0007380
Host Gene: NSUN2
Genomic location(hg19): chr5:6623326-6625782:-
Genomic location(hg38): chr5:6623213-6625669:-
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007576
MONDO name: esophageal cancer
Disease details: esophageal cancer
Disease DO ID:
5041
Disease MeSH ID:
-
Disease NCIt ID:
C7478
Disease ICD11 ID:
669033105
Disease OMIM ID:
133239
Species: Human
Species details: Homo sapiens
Tissue specimen:

esophagus cancer tissues; matched adjacent normal tissues; xenograft tumors

Cell lines:

ECA109; KYSE150; HET-1A

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: SPIN1 / spindlin1
Associated microRNA: miR-644a
Biological function: Hsa_circ_0007380 promotes esophagus cancer cell proliferation, cell cycle progression, tumor growth and radioresistance, while inhibiting apoptosis; its knockdown suppresses growth and enhances radiosensitivity in vitro and in vivo.
Molecular mechanism: Hsa_circ_0007380 functions as a competing endogenous RNA that sponges miR-644a, thereby relieving miR-644a-mediated suppression of SPIN1.
Biological pathway or process:

proliferation (promotes); apoptosis (inhibits); cell cycle (promotes); radioresistance (promotes); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Clinical Sample Validation; Transfection; MTT; EdU Staining; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry); RNA Pull-Down; Luciferase Reporter Assay; Bioinformatics Analysis

Clinical significance:

Potential therapeutic target for esophagus cancer combined treatment.

Description:

Hsa_circ_0007380 is up-regulated in esophagus cancer tissues and cell lines. It acts as an oncogenic circRNA that promotes proliferation, tumor growth and radioresistance while inhibiting apoptosis, mainly through the hsa_circ_0007380/miR-644a/SPIN1 ceRNA axis. Silencing hsa_circ_0007380 enhances radiosensitivity, suggesting therapeutic potential in combined treatment for esophagus cancer.

Confidence score:

0.8439

Other information
Title:

Hsa_circ_0007380 silencing restrains the growth and enhances radiosensitivity in esophagus cancer by miR-644a/Spindlin 1 axis.

Journal: Anti-cancer drugs
Published: 2023
PubMed ID: 36539369
Study type:

combined biological and clinical study

Data availability: -
Code availability: -